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Abstract — An useful electrochemical sensing approach 
was developed for norepinephrine (NE) detection based on 
semiconducting polymer (9-nonyl-2,7-di(selenophen-2-yl)-
9H-carbazole) and laccase modified platinum electrode (Pt). 
The miniature Pt biosensor was designed and constructed 
via  the immobilization of laccase in an electroactive layer of 
the electrode coated with thin polymeric film. This sensing 
arrangement utilized the catalytic oxidation of NE to 
norepinephrine quinone. The detection process was based 
on the oxidation of catecholamine in the presence of enzyme 
– laccase. With the optimized conditions, the analytical 
performance demonstrated selectivity in a wide linear range 
(0.1–200x10-6 M) with a detection limit of 240 nM and 
a quantification limit of 365 nM. Moreover, the method was 
successfully applied for selective NE determination in the 
presence of interfering substances. 
 
Keywords—biosensor, cyclic voltammetry, laccase, 
norepinephrine, point-of-care 
I. INTRODUCTION 
NE of the primary goals of world-wide scientific endeavors 
is to improve the quality of life. Achieving this assumption 
is directly related to the rapid analysis of common disorders, 
quality control in the food industry and environment 
monitoring. Constant, fast and sensitive in situ monitoring is a 
priority in diagnostic control, most of all, in medical diagnostic. 
The devices that meet these requirements are biosensors. The 
dynamic development of sensor technology in recent years and 
mutual cooperation of several scientific disciplines - biology, 
chemistry, electronics, and material engineering, enables the 
development and upgrading of research tools and measurement 
for quick and sensitive detection. The purpose of these devices 
is to control and evaluate, e.g. health status of patients, 
monitoring of the quality of food products and medicines, and 
study of changes in the environment. 
Recently, a pronounced increase of interest of 
neurotransmitters determination is observed. Neurotransmitters, 
such as epinephrine (EP), norepinephrine (NE), dopamine (DA) 
and serotonin (5-HT) belong to the group of catecholamines and 
play an essential role in the human organism as chemical 
messengers. These species are responsible for processes like 
“fight or flight” response, transmitting signals across a chemical 
synapse and modulating blood flow throughout the body. 
Neurotransmitters are present in human serum at nM level, 
nevertheless, any dysfunction of these catecholamines may lead 
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to numerously, serious health problems, like: Alzheimer 
disease, Parkinson disease, schizophrenia, depression, 
Huntington disease, severe head trauma, various neuroblastoma, 
adrenocortical carcinoma, pituitary adenoma, 
pheochromocytoma, and cancerous tumors or cardiovascular 
problems [1-4]. Due to this fact, rapid and sensitive 
catecholamines detection is extremely important in modern 
medicine, however, there is still any available device, which 
will show the concentration of these compounds in patient’s 
body.  
Many classical techniques allow to investigate 
catecholamines concentration in  the  sample, like high-
performance liquid chromatography (HPLC), gas 
chromatography (GC), spectrophotometry, chemiluminescence, 
electrochemistry, fluorescence-based measurements, capillary 
electrophoresis (CE) [5-10]. Still, most of these procedures are 
expensive, do not allow continuous monitoring, are active only 
for a short period of time or have low sensitivity and selectivity.  
From the literature are known biosensors for 
norepinephrine detection. Samdani et al. presented an 
electrochemical sensor for NE determination based on glassy 
carbon electrode (GCE) modified with FeMoO4 (FM) nanorods. 
Such a system has been able to catalyze the NE oxidation due to 
the formation of Fe (II)-dioxygen complexes. Cyclic 
voltammetry (CV) and differential pulse voltammetry (DPV) 
techniques have been employed for the characterization of the 
sensor. The amperometric response of NE on the FM/GCE 
showed a linear increase in the current between 5.0x10-8 M and 
2.0x10-4 M with a detection limit of 3.7x10-9M [11]. Another 
electrochemical detection system for NE and serotonin 
determination has been present by Wang et.al. The sensor has 
been fabricated by modification of screen-printed electrode 
(SPE) with multi-walled carbon nanotubes (MWNTs) and zinc 
oxide/chitosan (MWNTs-ZnO/chitosan SPE) complex. The 
electrochemical behavior of NE was investigated using CV and 
square wave voltammetry (SWV) techniques. The peak currents 
of NE was linearly dependent on its concentrations in the range 
of 0.5–30 μM, with the limit of detection of 0.2 μM. The 
modified electrode had been stored stably for at least 3 months 
at 4°C in a refrigerator [12]. Lu et al. describes the preparation 
and characterization of an electrodeposited DNA membrane 
doped with gold nanoparticles. The gold nanoparticles-doped 
DNA composite electrode was successfully used for the 
selective determination of norepinephrine in the presence of 
ascorbic acid (AA). A detection limit of 5 nM NE was obtained 
by using a DPV technique in static solutions [13].  
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The beginning of the use of diagnostic systems for point-
of-care (POC) research is considered to be the 60's and 70's of 
the 20th century, the date of development and implementation 
of a glucometer, an all-in-one apparatus enabling independent 
measurement of glucose in the blood. Towards the end of the 
1970s, one-time tests, such as pregnancy tests, have 
revolutionized the testing of disposable household products. 
Currently, we can find fertility tests, menopausal tests, tests 
detecting the presence of psychoactive substances, or the 
presence of infection. Designing devices allowing POC analysis 
in the clinical sense (enabling continuous monitoring of given 
substances) has been developing rapidly for two decades, 
enabling quick and sensitive "bedside" diagnostics [14]. POC 
testing is generally defined as tests that are performed away 
from the medical laboratory. There is still not any universal 
definition of such testing, however, any tests that can be done 
quickly, simply and without the need for sophisticated 
laboratory equipment is defined as POC. According to Peeling 
et al. the fundamental requirements for POC are accuracy, 
sensitivity, specificity, user-friendliness, rapid and robust, 
equipment-free and delivered (ASSURED) at settings away 
from traditional laboratory [15]. In comparison with 
conventional analytical testing POC possess many advantages, 
they are more efficient, the turnaround time for results is 
decreased, which is directly connected with faster patient 
diagnosis, allow for rapid response and continuous monitoring 
of critical parameters, they are portable and more convenient, an 
indirect costs by avoiding travel can be reduced [16].  
The semiconducting polymers are known to be excellent 
materials for the immobilization of biomolecules and rapid 
electron transfer for the fabrication of efficient biosensors. 
Conducting polymers (CPs) are an interesting alternative to 
organic polymers, which are mostly insulators. A characteristic 
feature of CPs is the presence of conjugated π electrons (a 
system having conjugated bonds C=C), thanks to which they 
exhibit unique electronic properties, such as low optical 
transition energy, low ionization potential and high electron 
affinities [17]. Due to the presence of aromatic units in the 
polymer backbone, the immobilization was performed with the 
help of π–π stacking interactions of the polymer and enzymatic 
protein. These strong interactions stabilize the tertiary structure 
of proteins effectively [18]. What is more, CPs are cheap, easy 
to synthesize and universal, because their properties can be 
easily modulated by physical changes (such as pH, temperature) 
even after their synthesis [19,20].  
In this study, we present a unique polymer-based 
electrochemical biosensor for the determination of 
norepinephrine level, based on an enzyme-dependent redox 
reaction. The novel procedure reported here may offer a few 
advantages: high sensitivity, application of stable materials, 
stable matrix for a protein anchoring, which also ensures 
stability during measurements and also simple and quick 
measurements. However, the main advantage over the other 
systems known from literature is the low detection limit and 
excellent selectivity. The fabricated platinum electrode 
modified with semiconducting polymer poly[9-nonyl-2,7-
di(selenophen-2-yl)-9H-carbazole] and laccase or exhibit 
exquisite electrochemical behavior. The presented study 
provides a simple, selective and sensitive method, making 
described biosensors a good tool for catecholamines detection.  
II. EXPERIMENTAL  
1) Reagents and materials  
Laccase (from Cerrena unicolor, EC 1.10.3.2, ≥10 U/mg), 
as well as norepinephrine hydrochloride (NE), 
tetrabutylammonium-tetrafluoroborate (TBA-TFB), 
dichloromethane, uric acid (UA), ascorbic acid (AA), L-
cysteine (CYS) were purchased from Sigma-Aldrich Co. Citric 
acid (CA), NaOH, NaH2PO4, Na2HPO4, KH2PO4, Tris, HCl, 
CH3COONa, CH3COOH, NaCl, KCl, glutaraldehyde (GA) 
were purchased from POCH (Part of  Avantor, Performance 
Materials, Poland). All chemicals were of analytical grade and 
were not further purified before use. All buffers needed to wash 
unbounded protein or to immobilization (phosphate buffer, 
acetate buffer and Tris-HCl) were prepared according to 
generally known, obligatory standards.  
 
2) Modification of electrode 
The platinum electrode (Pt electrode, diameter 3 mm, 
produced by BASi, MF-2013) was polished before experiment 
with 3 µm fine diamond polish and rinsed thoroughly with 
double distilled water. Such prepared electrode for NE 
determination was modified with a thin layer of poly[9-nonyl-
2,7-di(selenophen-2-yl)-9H-carbazole] and laccase. The 
synthesis of the monomer is described in the literature [21]. The 
electropolymerization of monomer was performed by 
a potentiostat/galvanostat AUTOLAB PGSTAT128N with 
GPES software. A three-electrode electrochemical cell (10 ml) 
equipped with a working electrodes (Pt), a silver-silver chloride 
reference electrode (Ag/AgCl), and a coiled platinum wire as 
the counter electrode, was used for all electrochemical 
experiments. All the electrochemical measurements were 
performed at room temperature. Due to synthesis of the 
polymeric layer onto a surface of the clean Pt electrode, 
monomer (1mM) was dissolved in a dichloromethane solution 
containing an electrolyte - 0.1 M tetrabutylammonium-
tetrafluoroborate (TBA-TFB). The electrodes were dipped into 
8 mL of the monomer solution. The polymer layers deposition 
was carried out through cyclic voltammetry (CV). The Pt 
electrode was scanned in a potential range 0.0 – 1.4 V vs 
Ag/AgCl for 10 cycles, at a scan rate of 50 mV/s. Then, the 
modified Pt electrode with poly[9-nonyl-2,7-di(selenophen-2-
yl)-9H-carbazole] was washed with dichloromethane. 
Knowledge about a biological element or recognition 
receptors, has a significant meaning due to biosensors 
designing, because the receptor plays a key role in the successful 
determination of the desired compound. Biomolecular 
recognition is related to non-covalent specific binding, and 
weak interactions (such as hydrophobic forces, Van der Waals 
force or hydrogen bonding) between molecules – in case of 
biosensors one is a biologically active material and the other is 
an analyte. Recently, there has been much progress in 
understanding the forces that drive the formation of such 
complexes, and how these forces are related to the physical 
properties of the interacting molecules and their environment 
allows rational design of molecules and materials that interact 
in specific and desired ways. Due to this, an assortment of the 
appropriate receptor and adequate platform for this bio-receptor 
is the most essential part in the design of biosensors. 
Immobilized biomolecules have to maintain their structure and 
their function, to retain their biological activity after 
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immobilization and to remain tightly bound to the surface. An 
ideal biosensor has to be stable for long-term applications. The 
type of immobilization method significantly affects the activity 
and stability of enzymatic biosensors. Physical immobilization 
is a simple and inexpensive method but there is a risk that the 
biocatalyst will be desorbed during the use of the device. 
Whereas chemical immobilization provides a strong and stable 
covalent bonding between the matrix and the enzyme, but it is 
an expensive and more complicated method and most 
importantly often results in protein conformational changes. 
The sensitivity of the sensor decreases if immobilization causes 
enzyme denaturation or if the enzyme has been modified, 
especially on its active site [22,23]. Each immobilization 
method presents advantages and drawbacks. The choice of the 
most appropriate technique depends on the enzyme nature, the 
transducer and the associated detection mode [24]. 
In this case, the immobilization processes were provided by 
physical adsorption of laccase in a phosphate-citric buffer (pH 
5.2) at room temperature onto the surface of polymer-modified 
Pt electrode This physical adsorption last for 2 h and then the 
setup was crosslinked with glutaraldehyde (GA) (10 minutes). 
Additional use of the GA for cross-linking allows a relatively 
stable and active immobilization of the proteins onto the 
electrode surface, because of covalent bonds creation.  
The excess of  unbounded proteins was washed with 
phosphate (pH 7.0), acetate (pH 5.2) and Tris-HCl (pH 7.2) 
buffers, respectively.  
Enzyme immobilized by physical adsorption with cross-
linker does not require any other activation. According to this 
procedure modified Pt-E/9-nonyl-2,7-di(selenophen-2-yl)-9H-
carbazole/Laccase electrode was obtained and was stored at 4ºC 
when not in use. The described modified electrode has been 
catalytically active for c.a. 90 reaction cycles. 
 
3) Electrochemical measurements 
Norepinephrine detection was performed using cyclic 
voltammetry (CV) with  a  potentiostat/galvanostat AUTOLAB 
PGSTAT128N with GPES software. The measurements were 
carried out with a typical three-electrode system in the 8-ml cell. 
The Pt electrode for NE detection modified with thin polymer 
film of poly[9-nonyl-2,7-di(selenophen-2-yl)-9H-carbazole] 
and laccase was used as  working electrode, together with a 
coiled platinum wire as the auxiliary electrode and  a silver-
silver chloride reference electrode (Ag/AgCl). Cyclic 
voltammetry (CV) measurements, showing the whole redox 
cycle were carried out by repeated potential scanning in range -
0.5 – 1 V. All  the  electrochemical measurements were 
performed at a scan rate of 50 mV/s, in room temperature with 
air-opened conditions. 
 
4) Influence of interfering substances 
Interfering substances (ascorbic acid (AA), uric acid (UA), 
L-cysteine (CYS) and mix of all interfering substances) in a 
concentration of 50 μM were added to NE standard solutions at 
concentration 1, 50 and 100 μM to check the interferences in 
deficiency, balance, and excess. Mentioned species were mixed 
each time with epinephrine solutions in volume ratio 1:1.  
III. RESULTS AND DISCUSSION 
1) Characterization of polymers 
A crucial problem in the design of enzymatic electrodes is to 
enhance the speed and reversibility of charge transfer between 
the enzyme and the electrode. In the electrochemical devices, 
where preservation of the enzyme activity at the 
nanocomposite/enzyme interface is vital for designing efficient 
electrodes, charge transfer between the enzyme and electrode 
should be fast and reversible. It has already been published that 
the use of conductive materials in the construction of biosensors 
(e.g. polymers [25]) improves the electron transport between the 
active site of the enzyme and the electrode surface, hence the 
sensor has short response time and high sensitivity. Biosensor 
efficiency depends mainly on the surface architecture, 
interaction among the enzyme and electrode surface and 
protection of the 3D structure of biocatalyst.  
Conductive polymer’s charge transfer capacity acts as an 
excellent matrix for biomolecules providing enzyme mimetic 
environment [18,26]. Due to the presence of aromatic units in 
the polymer backbone, the immobilization was performed with 
the help of π–π stacking interactions of the polymer and 
enzymatic protein. These strong interactions stabilize the 
tertiary structure of proteins effectively. In addition, one of the 
classes of compounds intended for electrode modification is 
bis(selenophene)carbazole derivatives. There are research 
results that prove that the presence of small amounts of selenium 
in the medium has a positive effect on the catalytic activity of 
laccase [27].  
In this paper polymer built of 9-nonyl-2,7-di(selenophen-2-
yl)-9H-carbazole (Fig. 1) has been electrochemically 
synthesized in the presence of 0.1 M TBA-TFB. The polymer 































Fig. 2. Cyclic voltammograms of investigated monomer - electropolymerization 
of 9-nonyl-2,7-di(selenophen-2-yl)-9H-carbazole (monomer concentration - 
1mM) in 0.1 M TBA-TFB. Measurement conditions: scan rate 50 mV/s, 
Ag/AgCl – reference electrode, 10 cycles. 
 
In order to obtain the conducting polymer on the Pt 
electrode, the cyclic voltammetry was used. The optimal 
potential range for polymer deposition was found to be 0.0 –1.4 
V and the polymerization lasted for 10 cycles. Figure 3 exhibit 
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the results of the electrochemical polymerization of the 
carbazole. The voltammograms demonstrate the formation of 
the electroactive polymer layers of 9-nonyl-2,7-di(selenophen-
2-yl)-9H-carbazole on the Pt electrode. The graph exhibits the 
increase of peak currents in subsequent scans, which suggests 
the embedding of the conducting polymer.  
 
2) Principle of electrochemical measurements and detection 
assays for neurotransmitters 
A bio-system for norepinephrine determination is the 
system using the Pt electrode modified with poly[9-nonyl-2,7-
di(selenophen-2-yl)-9H-carbazole] and laccase (Fig. 3) in the 
presence of a wide range of concentration of the NE (0.1 – 
200 μM).  
 
Fig. 3. Scheme of measuring platform for enzymatic norepinephrine 
determination 
 
In Figure 4A are presented results obtained for biosensor 
responses to the given NE concentration - as can be observed 
signals precisely respond to concrete NE concentration. The 
increased electrical signal is due to the charge (electron) 
released in the oxidation/reduction process, occurring between 
an enzyme - laccase and an analyte – norepinephrine. An 
oxidation peak of NE is c.a. 0.22 V. Biosensor response is in 
that case linear and proportional, as the concentration increases, 
at the same time, current increases. The electrochemical nature 
of NE was examined in a wide range of concentrations (0.1 - 
200 μM) employing the CV method (applied potential -0.5 – 1 
V, scan rate = 50 mV/s) in oxygen-saturated conditions for 20 
scans. Figure 4B presents the results of the linearity of the 
biosensor based on Pt-E/9-nonyl-2,7-di(selenophen-2-yl)-9H-
carbazole/Laccase with good linear response to NE in the 
investigated concentration range, a very good linear coefficient 
(R2=0.991) is also observed. The slope of the calibration curve 
is associated with the biosensor’s sensitivity which is related to 
the limit of detection (LOD). 
One of the most important parameter in the construction of 
biosensor is the limit of detection. LOD is the lowest 
concentration of analyte which can be checked with statistical 
certainty using the presented technique. The LOD was 
calculated with using the following equation: 




where 𝜎𝐵 is the standard deviation of the population of 
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Fig. 4A,B. A: Representative CV-scans for increasing concentration (NE 
concentration 70, 90, 120, 150, 200 μM); B: relationship between 5-HT 
concentration and current (biosensor response) 
 
The limit of detection for system is equal to 240 nM. The 
low detection limit demonstrates the ability of the constructed 
platform to detect low NE concentrations. This value can be 
compared with other biosensor systems for neurotransmitters 
determination  known from the literature (Table I). 
Additionally, the limit of quantification (LOQ) was also 
determined (calculated with using equation 2) and it equals 365 
nM. 
𝐿𝑂𝑄 = 5 ∙
𝜎𝐵
𝑏
   (2) 
 
where 𝜎𝐵 is the standard deviation of the population of blank 
responses and b is the slope of the regression line [28]. 
Parameters demonstrating an analytical validation are shown in 
Table II.  
  




COMPARISON OF BIOSENSORS AND SENSORS FOR NEUROTRANSMITTERS 
DETECTION 
Analyte Detection complex Measurement LOD Ref. 
Serotonin Catechin/Carbon 
Paste Electrode 






















ANALYTICAL PARAMETERS OF THE PRESENTED BIOSENSOR 
Linear range LOD LOQ R2 
0.1 – 200 μM 240 nM 365 nM 0.991 
 
The results presented for the biosensor are characterized by 
the wide linear range and low detection limit, which proves, that 
this constructed system may pretend to be a very good platform 




Presented here enzyme-based biosensor is designed for 
quantitative NE detection in  human body fluids’ samples. In 
that case, created bio-tool should be selective only for described 
neurotransmitter determination, not for any interfering species 
present in the sample. Human plasma or  urine contains a 
number of interfering substances, like the most common 
ascorbic acid (AA) and uric acid (UA) have high concentrations 
in the human body and possess similar oxidation potentials to 
NE. Interfering compounds may have an impact on oxidation 
peak potentials and current values during NE examination in 
human samples, which in consequence may lead to an incorrect 
result of a measurement. Figure 5 presents this compounds 
which can disturb signals obtained during measurements, 
including: ascorbic acid (AA), uric acid (UA), cysteine (CYS) 
and mix of all examined substances, which were added to 
























Fig. 5. Effect of interfering substances (50 μM) on NE determination 
 
 
All presented interfering species were added in 
concentration equals 50 μM to neurotransmitter samples to 
check the influence of these compounds in the high excess, 
equilibrium and deficiency of them. Each tested reagent has an 
insignificant effect (<5.2%) on the peak current of the samples 
compared to the blank. Presented results (Fig. 5) confirm, 
negligible impact on the selectivity of fabricated setups, and 
prove that existing interference does not interrupt the 
prominence of the proposed NE test. The biosensor exhibit an 
adequate selectivity for such catecholamine determination. 
IV. CONCLUSIONS 
Due to the global demand for quick and cheap analytical 
methods, the research which was carried out in this paper aimed 
at intensifying the work on the design of a new generation of 
miniature diagnostic devices with wide application possibilities. 
In summary, a rapid, sensitive, selective and simple biosensor 
system for the detection of norepinephrine has been developed 
using Pt electrode modified with 9-nonyl-2,7-di(selenophen-2-
yl)-9H-carbazole and laccase. The electrochemical 
measurements were carried out employing the cyclic 
voltammetry method. The biosensing assay demonstrates an 
exquisite electrocatalytic activity over a  linear concentration 
range (0.1 – 200 x 10-6 M) with a detection limit equal to 240 
nM. Obtained LOD value is comparative with a wide range of 
described electrochemical biosensor for norepinephrine 
detection, which proves that electrode modified with carbazole 
derivative in combination with laccase create very good 
material for  neurotransmitters investigation. In addition, the 
detection biosystem proved, that all examined interfering 
substances have a slightly effect on the signal during 
amperometric measurements (≤ 5.2 %). All characteristics made 
for biosensor establish a convenient, stable, simple and long-
term technique for neurotransmitters detection and recommend 
it as an excellent bio-tool for diagnostic. Our preliminary studies 
presented here, may lead to the creation of a sensitive, fast, 
biocompatible and selective bio-device suitable for single-use, 
disposable in vitro or in situ applications. 
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